- Straits Times Index3,205.71+0.17%
- Nikkei21,298.00-0.61%
- Hang Seng28,666.95+0.35%
- FTSE 1007,196.29+0.26%
- BTC-USD3,995.11+1.34%
- S&P 5002,818.46+0.72%
- Dow25,657.73+0.55%
- Nasdaq7,691.52+0.71%
- Gold1,317.00+0.15%
- Crude Oil60.03+0.15%
- 10-Yr Bond2.4140-0.25%
- FTSE Bursa Malaysia1,642.84-0.43%
- Jakarta Composite Index6,461.75-0.13%
- PSE Index7,874.68-0.41%
Aging Baby Boomers
1.39k followers • 11 symbols Watchlist by Yahoo Finance
This basket consists of stocks that benefit from the needs of aging baby boomers.
11 symbols
Get the Yahoo Finance app
- Free real-time data
- News and price alerts
- Add and edit holdings
- Track performance
- Create multiple watchlists
Yahoo Finance•6 hours agoStormy Daniels's lawyer Michael Avenatti could face uphill battle in Nike extortion case
Michael Avenatti is going on the offensive after federal prosecutors charged him with conspiring to extort Nike Inc.
- Zacks•5 hours ago
Procter & Gamble (PG) Outpaces Stock Market Gains: What You Should Know
Procter & Gamble (PG) closed the most recent trading day at $103.02, moving +1.04% from the previous trading session.
- Motley Fool•13 hours ago
Top Health Insurance Stocks for 2019
Here's what you need to know before investing in health insurance stocks this year.
- Market Realist•15 hours ago
What Analysts Expect for KMB and CL Stock
What’s Ahead for KMB and CL Stock?(Continued from Prior Part)Ratings and target prices Most analysts recommend “hold” for Kimberly-Clark (KMB) and Colgate-Palmolive (CL) stock. Both companies’ top and bottom lines are expected to fall in
Associated Press•yesterdayUS experts: Too soon to pull breast implants tied to cancer
Government medical advisers said Monday it's too soon to ban a type of breast implant that has recently been linked to a rare form of cancer, saying more information is needed to understand the problem. The Food and Drug Administration panel didn't recommend any immediate restrictions on breast implants after a day reviewing the latest research on the risks of the devices, which have been subject to safety concerns for decades. The FDA has been grappling with how to manage emerging science that shows the implants can trigger a rare form of lymphoma that grows in the scar tissue surrounding the breasts.
Reuters•yesterdayHedge fund Appaloosa unimpressed by Allergan board promises
Allergan agreed to split its chairman and chief executive roles, but only at its next leadership change. A source close to Allergan told Reuters on Friday that current Chairman and CEO Brent Saunders, 49, has no plans to step down. Appaloosa, led by billionaire David Tepper, has been pressing Allergan since last year to separate the roles of CEO and chairman.
Market Realist•yesterdayWhy Kimberly-Clark Stock’s Valuation Looks Unattractive
What’s Ahead for KMB and CL Stock?(Continued from Prior Part)Challenges continue to hurt sales and earningsKimberly-Clark (KMB) has beaten analysts’ sales estimates in the past two quarters, thanks to higher net prices. However, its sales have
- Market Realist•yesterday
What’s Ahead For KMB and CL Stock?
What’s Ahead for KMB and CL Stock?Stock performance Kimberly-Clark (KMB) and Colgate-Palmolive (CL) have been strong this year, driven by improved organic sales due to higher pricing. However, near-term sales and earnings weakness could weigh on
- Barrons.com•yesterday
Allergan Stock Is Falling Because It’s Facing Off With an Activist Investor
Allergan stock was trading down as shareholders digested its 2019 proxy statement, in which the company butted heads with activist investor Appaloosa.
- Zacks•2 days ago
Coty's (COTY) Luxury Unit Strong, Consumer Beauty Woes Remain
Coty (COTY) is largely benefitting from strength of its Luxury segment that accounted for about 40% of the top line in Q2. However, supply-chain hurdles continue to mar Consumer Beauty unit.
- Motley Fool•3 days ago
3 Top Insurance Stocks to Buy in March
These three insurance stocks have potential.
- Motley Fool•3 days ago
Better Buy: Procter & Gamble vs. Kimberly-Clark
Which of these dividend stalwarts is the best investment today?
- Zacks•4 days ago
Amazon Unveils Belei to Boost Private Label Initiatives
Amazon (AMZN) unveils private-label skincare line called Belei to expand its share in the private label business.
- Market Realist•4 days ago
Weak European Data Are Bothering US Investors
Top US Companies Impacted by Slowing European EconomyUS stock marketEarly on March 22, US stock indexes were trading on a negative note. On March 21, the stock indexes ended on a bullish note. On March 21, the S&P 500 Index, the NASDAQ
- Zacks•5 days ago
UnitedHealth Group (UNH) Gains But Lags Market: What You Should Know
UnitedHealth Group (UNH) closed at $252.02 in the latest trading session, marking a +0.61% move from the prior day.
- Zacks•6 days ago
Zacks Market Edge Highlights: Edwards Lifesciences, Exact Sciences, Aimmune Therapeutics, Allergan and Evolus
Zacks Market Edge Highlights: Edwards Lifesciences, Exact Sciences, Aimmune Therapeutics, Allergan and Evolus
Market Realist•6 days agoWhy Analysts Remain on Sidelines for CHD and CLX
What's Ahead for Church & Dwight and Clorox?(Continued from Prior Part)Valuation a concernThe majority of analysts covering Church & Dwight (CHD) and Clorox (CLX) stock maintain a neutral outlook despite better growth prospects among peers.
- Zacks•6 days ago
Will Dow Rally Continue in the Long Term? 4 Top Picks
Positive development on the trade war front and the Fed???s dovish monetary stance are likely to be long-term catalysts for the blue-chip index.
- Zacks•6 days ago
NASH, Allergies and Beauty Stocks: Invest or Not?
There's a lot of innovation going on at the biopharmaceutical companies but which areas should investors be targeting?
- Barrons.com•6 days ago
Allergan Stock Won’t Benefit From a Breakup, Analyst Says
Share are up 15% year to date, helped by the FDA’s acceptance of new applications for Botox. Still, questions remain about the health of the drugmaker’s pipeline and earnings profile.
- Zacks•6 days ago
WellCare Health Arm MeridianRx Unveils Mobile Application
WellCare Health (WCG) unit introduces a unique mobile app, Atlas Compass, to assist PBM members to manage their pharmacy health information.
- Market Realist•6 days ago
Will Innovation and Higher Pricing Drive Clorox Stock?
What's Ahead for Church & Dwight and Clorox?(Continued from Prior Part)Top line to sustain momentum Clorox (CLX) could continue to report healthy sales growth despite pressure on net sales from currency volatility. Management expects its top
- Zacks•6 days ago
Conatus (CNAT) Focuses on Developing NASH Candidate Emricasan
Conatus (CNAT) concentrates on the development of its lead candidate, emricasan, for treating patients with fibrosis or cirrhosis caused by NASH.
- Zacks•6 days ago
Universal Health's Acute Care Segment Solid, High Debt Ails
Riding high on solid segmental performances, Universal Health (UHS) promises to reap great benefits for investors. However, its debt load bothers.
